The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome
Abstract
MicroRNA (miRNA)-mediated RNA interference regulates many immune processes, but how miRNA circuits orchestrate aberrant intestinal inflammation during inflammatory bowel disease (IBD) is poorly defined. Here, we report that miR-223 limits intestinal inflammation by constraining the nlrp3 inflammasome. miR-223 was increased in intestinal biopsies from patients with active IBD and in preclinical models of intestinal inflammation. miR-223-/y mice presented with exacerbated myeloid-driven experimental colitis with heightened clinical, histopathological, and cytokine readouts. Mechanistically, enhanced NLRP3 inflammasome expression with elevated IL-1β was a predominant feature during the initiation of colitis with miR-223 deficiency. Depletion of CCR2+ inflammatory monocytes and pharmacologic blockade of IL-1β or NLRP3 abrogated this phenotype. Generation of a novel mouse line, with deletion of the miR-223 binding site in the NLRP3 3′ untranslated region, phenocopied the characteristics of miR-223-/y mice. Finally, nanoparticle-mediated overexpression of miR-223 attenuated experimental colitis, NLRP3 levels, and IL-1β release. Collectively, our data reveal a previously unappreciated role for miR-223 in regulating the innate immune response during intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies have established that miR-223 could bind to specific target genes to inhibit the production of inflammatory mediators or block inflammation signaling pathways, which protect the body from inflammation-induced injury 11, 70-81.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [76]
In the citing paper
“The increase in miR-223 expression caused the down-regulation of NLRP3 inflammasome and IL-1β secretion, reducing IBD severity (Figure 9) 76.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Self-citationInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826
The NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
Research works printed but not linked: 43
- Andres, 2000, Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine, J. Immunol., 164, 6303, 10.4049/jimmunol.164.12.6303 · DOI · Paper page
- Bamias, 2012, New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation, Cytokine., 59, 451, 10.1016/j.cyto.2012.06.014 · DOI
- Bauer, 2010, Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome, Gut., 59, 1192, 10.1136/gut.2009.197822 · DOI · Paper page
- Bauernfeind, 2012, NLRP3 inflammasome activity is negatively controlled by miR-223, J. Immunol., 189, 4175, 10.4049/jimmunol.1201516 · DOI · Paper page
- Bersudsky, 2014, Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice, Gut., 63, 598, 10.1136/gutjnl-2012-303329 · DOI · Paper page
- Brazil, 2013, The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease, Inflamm. Bowel Dis., 19, 1556, 10.1097/MIB.0b013e318281f54e · DOI
- Calkins, 2002, IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia, J. Endotoxin Res., 8, 59
- Casini-Raggi, 1995, Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation, J. Immunol., 154, 2434, 10.4049/jimmunol.154.5.2434 · DOI · Paper page
- Cominelli, 1990, Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins, J. Clin. Invest., 85, 582, 10.1172/JCI114476 · DOI
- Dorhoi, 2013, MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment, J. Clin. Invest., 123, 4836, 10.1172/JCI67604 · DOI · Paper page
- Elinav, 2011, NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis, Cell., 145, 745, 10.1016/j.cell.2011.04.022 · DOI · Paper page
- Eulalio, 2012, The mammalian microRNA response to bacterial infections, RNA Biol., 9, 742, 10.4161/rna.20018 · DOI · Paper page
- Gentner, 2009, Stable knockdown of microRNA in vivo by lentiviral vectors, Nat. Methods., 6, 63, 10.1038/nmeth.1277 · DOI · Paper page
- Haneklaus, 2012, Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production, J. Immunol., 189, 3795, 10.4049/jimmunol.1200312 · DOI · Paper page
- Haneklaus, 2013, miR-223: Infection, inflammation and cancer, J. Intern. Med., 274, 215, 10.1111/joim.12099 · DOI · Paper page
- Hsu, 2012, Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver, J. Clin. Invest., 122, 2871, 10.1172/JCI63539 · DOI · Paper page
- Huang, 2006, RegRNA: An integrated web server for identifying regulatory RNA motifs and elements, Nucleic Acids Res., 34, W429, 10.1093/nar/gkl333 · DOI · Paper page
- Janssen, 2013, Treatment of HCV infection by targeting microRNA, N. Engl. J. Med., 368, 1685, 10.1056/NEJMoa1209026 · DOI · Paper page
- Johnnidis, 2008, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223, Nature., 451, 1125, 10.1038/nature06607 · DOI · Paper page
- Karmakar, 2015, Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux, J. Immunol., 194, 1763, 10.4049/jimmunol.1401624 · DOI · Paper page
- Li, 2010, MicroRNAs modulate the noncanonical transcription factor NF-κB pathway by regulating expression of the kinase IKKα during macrophage differentiation, Nat. Immunol., 11, 799, 10.1038/ni.1918 · DOI · Paper page
- Ligumsky, 1990, Role of interleukin 1 in inflammatory bowel disease: Enhanced production during active disease, Gut., 31, 686, 10.1136/gut.31.6.686 · DOI · Paper page
- Lopetuso, 2013, Opposing functions of classic and novel IL-1 family members in gut health and disease, Front. Immunol., 4, 181, 10.3389/fimmu.2013.00181 · DOI
- Mankan, 2012, The NLRP3/ASC/caspase-1 axis regulates IL-1β processing in neutrophils, Eur. J. Immunol., 42, 710, 10.1002/eji.201141921 · DOI · Paper page
- McNamee, 2010, Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse, Inflamm. Bowel Dis., 16, 743, 10.1002/ibd.21148 · DOI
- McNamee, 2011, Interleukin 37 expression protects mice from colitis, Proc. Natl. Acad. Sci. USA., 108, 16711, 10.1073/pnas.1111982108 · DOI · Paper page
- Mosser, 2008, Activation of murine macrophages, Curr. Protoc. Immunol., Chapter 14, Unit 14.2, 10.1002/0471142735.im1402s83 · DOI · Paper page
- Nagler-Anderson, 2001, Man the barrier! Strategic defences in the intestinal mucosa, Nat. Rev. Immunol., 1, 59, 10.1038/35095573 · DOI · Paper page
- Nowarski, 2015, Epithelial IL-18 equilibrium controls barrier function in colitis, Cell., 163, 1444, 10.1016/j.cell.2015.10.072 · DOI · Paper page
- O’Connell, 2010, Physiological and pathological roles for microRNAs in the immune system, Nat. Rev. Immunol., 10, 111, 10.1038/nri2708 · DOI · Paper page
- Polytarchou, 2015, Assessment of circulating microRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology, Inflamm. Bowel Dis., 21, 2533, 10.1097/MIB.0000000000000547 · DOI
- Pulikkan, 2010, Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia, Blood., 115, 1768, 10.1182/blood-2009-08-240101 · DOI · Paper page
- Ramkissoon, 2006, Hematopoietic-specific microRNA expression in human cells, Leuk. Res., 30, 643, 10.1016/j.leukres.2005.09.001 · DOI · Paper page
- Reinecker, 1993, Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease, Clin. Exp. Immunol., 94, 174, 10.1111/j.1365-2249.1993.tb05997.x · DOI · Paper page
- Satsangi, 2006, The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications, Gut., 55, 749, 10.1136/gut.2005.082909 · DOI · Paper page
- Schaefer, 2011, Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon, J. Immunol., 187, 5834, 10.4049/jimmunol.1100922 · DOI
- Seo, 2015, Distinct commensals induce interleukin-1β via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury, Immunity., 42, 744, 10.1016/j.immuni.2015.03.004 · DOI · Paper page
- Shouval, 2016, Interleukin 1β mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency, Gastroenterology., 151, 1100, 10.1053/j.gastro.2016.08.055 · DOI · Paper page
- Song-Zhao, 2014, Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen, Mucosal Immunol., 7, 763, 10.1038/mi.2013.94 · DOI
- Zaki, 2010, The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis, Immunity., 32, 379, 10.1016/j.immuni.2010.03.003 · DOI · Paper page
- Zhang, 2014, Inflammasome activation has an important role in the development of spontaneous colitis, Mucosal Immunol., 7, 1139, 10.1038/mi.2014.1 · DOI
- Zhou, 2015, MicroRNA-223 regulates the differentiation and function of intestinal dendritic cells and macrophages by targeting C/EBPβ, Cell Reports., 13, 1149, 10.1016/j.celrep.2015.09.073 · DOI · Paper page
- Zigmond, 2012, Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells, Immunity., 37, 1076, 10.1016/j.immuni.2012.08.026 · DOI · Paper page
Cited by
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
Tahamtan, A., Teymoori-Rad, M., Nakstad, B., & Salimi, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01377 · Cited by 357
Tong, L., Hao, H., Zhang, Z., Lv, Y., Liang, X., Liu, Q., Liu, T., Gong, P., Zhang, L., Cao, F., et al. (2021) · Theranostics · doi:10.7150/thno.62046 · Cited by 325
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Calvente, C. J., Tameda, M., Johnson, C. D., del Pilar, H., Lin, Y. C., Adronikou, N., De Mollerat Du Jeu, X., Llorente, C., Boyer, J., & Feldstein, A. E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122258 · Cited by 268
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Metadata
- Authors
- Neudecker, V., Haneklaus, M., Jensen, O., Khailova, L., Masterson, J. C., Tye, H., Biette, K., Jedlicka, P., Brodsky, K. S., Gerich, M. E., Mack, M., Robertson, A. A. B., Cooper, M. A., Furuta, G. T., Dinarello, C. A., O’Neill, L. A., Eltzschig, H. K., Masters, S. L., & McNamee, E. N.
- Affiliations
- Clinic for Anesthesiology, University Hospital of Ludwig-Maximilians-University, 80539 Munich, Germany 1
- School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland 2
- Mucosal Inflammation Program, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045 13
- Department of Anesthesiology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045 14
- Gastrointestinal Eosinophilic Disease Program, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Hospital Colorado, Aurora, CO 80045 3
- Division of Inflammation, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia 4
- Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045 10
- Division of Gastroenterology and Hepatology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045 11
- Department of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany 6
- Institute for Molecular Bioscience, The University of Queensland, Brisbane City, QLD 4067, Australia 7
- Department of Medicine, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands 9
- Department of Anesthesiology, University of Texas Medical School at Houston, Houston, TX 77030 8
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-05-09
- Volume
- 214
- Issue
- 6
- Pages
- 1737-1752
- ISSN
- 0022-1007
- 1540-9538
- Cited by
- 356
- References
- 6
- Language
- en
- Funders
- German Research Foundation
- American Heart Association
- National Institutes of Health (K01DK106315, R01 DK097075, R01- HL098294, POI-HL114457, R01-DK082509, R01-HL109233, R01-DK109574, R01-HL119837, R01-HL133900)
- NASPGHAN Foundation
- Crohn’s and Colitis Foundation of America (3760)
- National Health and Medical Research Council (1057815, 1099262, 361646)
- Victorian Endowment for Science Knowledge and Innovation
- State Government of Victoria
- GlaxoSmithKline
- CCFA (273007, 409992)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. https://app.cochat.ai/papers/10.1084/jem.20160462
- The paper
- Neudecker, V., Haneklaus, M., Jensen, O., Khailova, L., Masterson, J. C., Tye, H., Biette, K., Jedlicka, P., Brodsky, K. S., Gerich, M. E., Mack, M., Robertson, A. A. B., Cooper, M. A., Furuta, G. T., Dinarello, C. A., O’Neill, L. A., Eltzschig, H. K., Masters, S. L., & McNamee, E. N. (2017). Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20160462
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.